🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Pennsylvania › Philadelphia

Etid klinik pou Maladi poumon entèstisyèl nan Philadelphia, PA

16 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Ap rekriteFaz 3
  • University of Pennsylvania, Philadelphia
  • Temple University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Ap rekriteFaz 3
  • University of Pennsylvania, Philadelphia
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteFaz 2
  • Thomas Jefferson University, Philadelphia
  • Temple Lung Center, Temple University, Philadelphia
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Ap rekriteFaz 3
  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06716606

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Ap rekriteFaz 3
  • GSK Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Ap rekriteFaz 2/3
  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Ap rekrite
  • Thomas Jefferson University, Philadelphia
  • Temple University of The Commonwealth System of Higher Education, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteEtid obsèvasyon
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
  • Temple Lung Center, Philadelphia
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Ap rekriteFaz 2
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Ap rekriteEtid obsèvasyon
  • Temple University, Philadelphia
  • Thomas Jefferson University, Philadelphia
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Ap rekriteFaz 3
  • Hospital of the University of Pennsylvania, Philadelphia
  • Jefferson Honickman Center, Philadelphia
  • Temple University Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
Jiska laj 24 · Tout sèks · Mizajou Jun 22, 2026 · NCT04098445

Feasibility of Semaglutide in Advanced Lung Disease

Ap rekriteFaz 1/2
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
Laj 18 a 80 · Tout sèks · Mizajou Apr 21, 2026 · NCT05746039

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Ap rekriteFaz 2
  • Temple University Hospital-Temple Lung Center, Philadelphia
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Etid Maladi poumon entèstisyèl nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.